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Introduction: This study examined whether psychosocial variables influenced patients’ perception and experience
of side effects of their medicines, how they coped with these experiences and the impact on medication
adherence behaviour.
Methods: A hospital-based mixed methods study using quantitative and qualitative approaches was conducted
with hypertensive patients. Participants were asked about side effects, medication adherence, common psychological
symptoms and coping mechanisms with the aid of standard questionnaires and an interview guide.
Results: The experiences of side effects—such as palpitations, frequent urination, recurrent bouts of hunger, erectile
dysfunction, dizziness, cough, physical exhaustion—were categorized as no/low (39.75 %), moderate (53.0 %) and high
(7.25 %). Significant relationships between depression (x2 = 24.21, p < 0.0001), anxiety (x2 = 42.33, p < 0.0001), stress
(x2 = 39.73, p < 0.0001) and side effects were observed. A logistic regression model using the adjusted results for
this association is reported—depression [OR = 1.9 (1.03–3.57), p = 0.04], anxiety [OR = 1.5 (1.22–1.77), p ≤ 0.001]
and stress [OR = 1.3 (1.02–1.71), p = 0.04]. Side effects significantly increased the probability of individuals to be
non-adherent [OR = 4.84 (95 % CI 1.07–1.85), p = 0.04] with social factors, media influences and attitudes of primary care
givers further explaining this relationship. Personal adoption of medication modifying strategies, espousing the use of
complementary and alternative treatments and interventions made by clinicians were the main forms of coping with
side effects.
Discussion: Results from this study show that, in addition to a biomedical approach, the experience of side
effects has biological, social and psychological interrelations. The results offer more support for the need for a
multi-disciplinary approach to healthcare where all forms of expertise are incorporated into health provision and
patient care.
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Hypertension refers to a chronic medical condition re-
lating to an elevation in blood pressure. A review of
population-based studies on hypertension in Ghana has
showed that the prevalence of hypertension is around
54.6 % in urban and 19.3 % in rural communities [1].
Although worldwide prevalence in the year 2000 was
estimated at 26 % totalling approximately 1 billion people,
it has been projected to increase to 29 % by the year 2025
due to the expectation that a greater proportion of the
world’s population will be older by that year [2]. Hyperten-
sion is the leading risk factor for cardiovascular diseases
and is a major cause of death globally [3, 4]. Similarly,
hypertension is a major risk factor when taking into ac-
count death and disability worldwide, and it accounted for
9.4 million deaths and 7 % of disability adjusted life years
(DALYs) in 2010 [3].
Although hypertension is an incurable condition, it can
be managed with the help of medications and lifestyle
modifications. The main goal of treatment is to reduce
blood pressure and consequently lessen the risk of compli-
cations. Treatment of hypertension is usually based on
country-specific guidelines such as the Joint National
Committee (JNC8) and the Ghana Standard Treatment
(STG6) Guidelines [5].
Medicines such as alpha blockers, angiotensin-converting
enzyme inhibitors, angiotensin receptor blockers, beta
blockers, calcium channel blockers, central alpha agonists,
diuretics, renin inhibitors and vasodilators as well as exer-
cise, weight loss and healthier diet therapies are prescribed
in order to achieve optimum blood pressure control [6].
Common side effects associated with the medications
include dizziness, fatigue, cough, headache, confusion,
depressed mood, chest pain, difficulty breathing, constipa-
tion, diarrhoea, swelling in parts of the body, reduced sex
drive, erectile dysfunction, persistent cough, increased
frequency of urination, rash and difficulty sleeping [6].
Although these adverse effects, as well as common psy-
chological problems like depression and anxiety, have
been noted to decrease medication adherence [7–9], some
patients have associated and interpreted the effectiveness
of their medications with the extent to which adverse
events are experienced by them, thereby improving their
adherence to therapy [10].
This study therefore sought to examine the role of
psychosocial variables in influencing how patients per-
ceived the side effects associated with their medicines,
how they coped with these experiences and the impact
on adherence to conventional hypertension therapies.
Methods
Study design and setting
A hospital-based mixed methods study, using quantitative
and qualitative approaches was conducted with hypertensivepatients from May to November 2012. The rationale for
including the qualitative phase was to triangulate the
quantitative phase of the study. The study was conducted
at the two major tertiary hospitals in Ghana—Korle Bu
Teaching Hospital (KBTH), Accra and Komfo Anokye
Teaching Hospital (KATH), Kumasi. The KBTH is the
premier and largest teaching hospital located in the Accra
District of Greater Accra Region and the second largest
hospital in the West African subregion. Being the only ter-
tiary hospital in southern Ghana, KBTH is the main centre
for the provision of healthcare for the people of Accra and
other surrounding urban towns located southwards. Komfo
Anokye Teaching Hospital is the second largest hospital in
the country and serves as the main facility for referrals from
the northern parts of Ghana. In selecting these two hospi-
tals, it is assumed that research participants with diverse
experiences would be recruited to fairly represent both
southern and northern parts of Ghana to allow for some
degree of generalization of results.
Participants
Four hundred (400) hypertensive outpatients were re-
cruited from the two hospitals in Ghana using simple
random sampling techniques. The minimum sample
size was determined using the estimated prevalence of
hypertension at the time of study (28.7 %) and a 95 %
confidence interval [11]. Patients who were at least
18 years old with a diagnosis of hypertension only or
hypertensive with other comorbid conditions were in-
cluded. Only patients reporting a prescription of at least
one antihypertensive medication for a minimum of 2
months were included. Additionally, inpatients, pregnant
women (because of the prospect of gestational hyperten-
sion resolving after delivery), newly diagnosed patients
as well as the physically and mentally incapacitated were
excluded from the study.
Measures
After obtaining informed consent from the 200 recruited
study participants from each study site, a researcher-
administered structured questionnaire was used to gather
data. Information was obtained on demographic char-
acteristics, experiences of medication side effects, nega-
tive emotional experiences and medication adherence
behaviour.
The Hypertensive Medication Side Effect Experience
Scale (HMSEES) assessed the frequency of experiences
with various possible side effects associated with different
antihypertensive medications. Some examples of the 18-
item list of side effects included fatigue, cough, headache,
chest pain, difficulty breathing, increased frequency of
urination, reduced sex drive and erectile dysfunction.
Participants indicated the frequency of experiences on
a 5-point scale that ranged from never (0), rarely (1),
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ranging from 0–72. These were then categorized as no
side effects (0), low side effects (1–18), moderate side ef-
fects (19–36) and high side effects (37 and above). The
HMSEES showed a good reliability of 0.801.
The Depression Anxiety Stress Scale (DASS) is a 21-
item self-report inventory that measures the negative
emotional states of depression, anxiety and stress. De-
pression was assessed around themes such as dysphoria,
hopelessness, devaluation of life, self-depreciation, and
lack of interest/involvement, anhedonia and inertia. The
subscale on anxiety measured autonomic arousal, skeletal
muscle effects, situational anxiety and subjective experience
of anxious affect. In relation to stress, items such as relax-
ation difficulty, nervous arousal, agitation, irritability and
impatience were measured. Participants were requested to
use a 4-point severity scale to rate the extent to which they
experienced each negative state over the past week. The re-
liability coefficients for the three scales have been reported
as 0.71, 0.79 and 0.81 for depression, anxiety and stress,
respectively [12].
Medication adherence was assessed with the 8-item
Morisky Medication Adherence Scale (MMAS). The
MMAS scores range from 0 to 8 and to be grouped as
low adherence, medium adherence and high adherence
on the basis of the number of positive responses ob-
tained. Patients who scored low and moderate were
grouped as poor adherent. The reliability measure was
0.83 for a study on hypertensive outpatients [13] and
0.793 for this study.
Additionally, an exploratory interaction using one-on-
one semi-structured in-depth interviews assessed the views
of fifteen participants on side effects, coping and adherence
behaviour. The data were saturated when 15 patients had
participated in the qualitative study. The interviews were
guided by a range of questions on general medication use
issues such as (“Is there anything about your medications
you don’t like?”) its relation with medication adherence
(“Why does this pose a problem to the management of
your hypertensive condition?”) and recommendations for
improved adherence behaviour (“In your view, what are the
possible best ways to solve these problems you stated earl-
ier?”). The moderation was done by one of the researchers.
Each interview lasted about 40 min.
Ethical considerations
The study was approved by the Institutional Review Board
at Noguchi Memorial Institute for Medical Research,
Accra and Committee of Human Research, Publications
and Ethics, Kumasi with the approval codes as NMIMR-
IRB CPN 044/10-11 and CHRPE/AP/022/12, respectively.
Permission was obtained from the hospital authorities be-
fore data were collected. Participation in the study was
strictly voluntary and participants enrolled after informedwritten consent has been obtained from them. Each
participant in the qualitative study also consented to the
recording of interviews. To ensure that patients and their
information were respectively anonymous and confiden-
tial, each participant was assigned an identification code
which has been used in presenting the results.
Data analysis
Data from the quantitative phase was analysed with the
Statistical Package for Social Sciences (SPSS) version 20
and presented statistically as descriptive and inferential.
The relationship between psychological problems, side
effects and medication adherence were evaluated using
chi-square tests and logistic regression models. The in-
terviews from the qualitative study were audio-taped
with a digital audio recorder, manually transcribed and
analysed using thematic content analysis. Analysis was
performed through a coding process to identify and re-
port patterns. Six phases were involved and this included
familiarization with data, generating initial codes, search-
ing for themes among codes, reviewing themes, defining
and naming themes and producing the final report. The
themes originated from participant interviews a posteriori.
Results
Sample characteristics
The characteristics of the patients are summarized and
presented in Table 1. Approximately 63 % of the partici-
pants were women, 33 % were 50 to 59 years old, 64 %
were married, 54 % had obtained secondary school edu-
cation and 80 % had hypertension for ≥10 years.
Experiences of side effects
The side effects experienced by patients using the
HMSSES are presented in Table 2. These experiences
are categorized as no/low (39.75 %), moderate (53.0 %)
and high (7.25 %). From the qualitative interviews, partici-
pants mentioned palpitations, frequent urination, recurrent
bouts of hunger, erectile dysfunction, dizziness, headache,
cough, physical exhaustion and weakness. A female partici-
pant reported,
When I take the drugs I was given, in about 20–30
minutes my heart will be beating fast and even my
whole body will be shaking …I urinate a lot and feel
very hungry in the mornings. (R1: female).
Moreover, the concern of a male participant was
expressed in the following:
I lose erection. That is the main thing that is worrying
me so much. Sometimes I don’t perform well sexually,
my wife complains and there’s a problem at home.
(R5: male).
























Number of years of having hypertension
≤10 years 318 79.50
11–20 years 49 12.25
21–30 years 20 5.00
31–40 years 12 3.00
41–50 years 1 0.25
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taking the medicines, the lack of thorough laboratory
investigations, the chemical composition of their medicines
and the daily intake of the medicines were the main factors
accounting for the side effects they experienced. These
views have been reported by the ensuing comments:
We don’t have funds otherwise before a medication is
administered to a patient a lot of laboratory tests have to be
done so that we don’t have these problems. (R3: female).
The drugs are not natural. They contain serious
chemicals and that is why we are suffering from the
effect of the chemicals. (R5: male).
Psychological symptoms and experience of side effects
The presence of symptoms of common psychological
conditions like depression, anxiety and stress (Table 3) may
influence the side effects experienced by patients (n = 400).Significant relationships between depression (x2 = 24.21,
p < 0.0001), anxiety (x2 = 42.33, p < 0.0001), stress (x2 =
39.73, p < 0.0001) and side effects were observed. A logistic
regression model using the adjusted results for the associ-
ation between depression, anxiety, stress and side effects
are shown in Table 4. Participants with depression, anxiety
and stress respectively had a 1.9, 1.5 and 1.3 times increased
likelihood to experience side effects than those without
these psychological symptoms.
Medication side effects and adherence
Medication adherence behaviour of patients was assessed
using MMAS (Table 5). After controlling for demographic
characteristics (age, sex, education) and clinical character-
istics (hypertensive years, comorbidities, number of medi-
cines), the results indicated that side effects significantly
increased the probability of non-adherence [OR = 4.84
(95 % CI 1.07–1.85), p = 0.04] (Table 6). Given this quanti-
tative finding, the exploration from the qualitative inter-
views revealed that social factors, media influences and
attitudes of primary caregivers further explained this rela-
tionship between side effects and adherence.
Social factors Some participants experienced erectile
dysfunction as a result of the medication side effects,
and the desire to sexually satisfy partners came up as a
hindrance to medication adherence. The concern of a
male respondent was expressed as follows:
Sometimes I stop taking the medication because my
wife is complaining I don’t perform well. If the drug
problem is posing problems for me in the room what
do I have to do; either I stop taking it or I fall on the
supplementary ones. (R5: male).
Media influences Some patients did not adhere as a re-
sult of information about medicines obtained from the
media which caused trepidation. The fears of a partici-
pant were articulated as follows:
I don’t take my medicine all the time because I
listened to a man on …. FM who said that some of
the hypertension drugs can cause liver or kidney
cancer. (R1: female).
Attitudes of doctors The perceived negative attitude of
primary care givers towards patients hindered the
intention of some participants to adhere to medications
as a result of the side effects. A male respondent did not
adhere adequately because:
Our doctors have certain attitudes that are very
obnoxious sometimes….. because if I go to the doctor
and I say I think I have a problem with my medicine…,
Table 2 Experiences of medication side effects
Side effect Never Rarely Sometimes Very often Always
n (%) n (%) n (%) n (%) n (%)
Dizziness 179 (44.75) 61 (15.25) 124 (31.00) 31 (7.75) 5 (1.25)
Fatigue 79 (19.75) 29 (7.25) 128 (32.00) 112 (28.00) 52 (13.00)
Cough 197 (49.25) 80 (20.00) 93 (23.25) 24 (6.00) 6 (1.50)
Headache 89 (22.25) 50 (12.50) 186 (46.50) 50 (12.50) 25 (6.25)
Confusion 201 (50.25) 102 (25.50) 88 (22.00) 8 (2.00) 1 (0.25)
Depressed mood 189 (47.25) 108 (27.00) 85 (21.25) 16 (4.00) 2 (0.50)
Chest pain 220 (55.00) 56 (14.00) 89 (22.25) 27 (6.75) 8 (2.00)
Difficulty breathing 251 (62.75) 49 (12.25) 75 (18.75) 17 (4.25) 8 (2.00)
Fainting 327 (81.75) 35 (8.75) 24 (6.00) 10 (2.50) 4 (1.00)
Constipation 142 (35.50) 97 (24.25) 117 (29.25) 28 (7.00) 16 (4.00)
Diarrhoea 206 (51.50) 105 (26.25) 77 (19.25) 8 (2.00) 4 (1.00)
Flu-like symptoms 156 (39.00) 130 (32.50) 80 (20.00) 25 (6.25) 9 (2.25)
Swelling in the ankle/feet 206 (51.50) 51 (12.75) 77 (19.25) 47 (11.25) 19 (4.75)
Increased frequency of urination 82 (20.50) 34 (8.50) 99 (24.75) 104 (26.00) 81 (20.25)
Reduced sex drive 86 (21.50) 47 (11.75) 105 (26.25) 56 (14.00) 106 (26.50)
Erectile dysfunction (impotence) 335 (83.75) 19 (4.75) 19 (4.75) 14 (3.50) 13 (3.25)
Rash 278 (69.50) 75 (18.75) 37 (9.25) 9 (2.25) 1 (0.25)
Difficulty sleeping 167 (41.75) 50 (12.50) 111 (27.75) 36 (9.00) 36 (9.00)
No = never, low = rarely, moderate = sometimes, high = very often and always. No/low side effects = 39.75 %, moderate side effects = 53.0 %, high
side effects = 7.25 %
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fever. It’s like I am a novice. I will expect the doctor who
knows more to allow me to pour all the nonsense I have
concerning my condition so that he will pick out what is
good from the nonsense that I have said. (R8: male).
Coping with side effects
In coping with the problems associated with patients’
medication intake, three interrelated subthemes emerged
from the interviews. Some patients personally adopted
medication modification strategies; others espoused the
use of complementary and alternative treatments, while
some relied on the interventions made by their doctors.
Direct personal effort Among patients who took direct
responsibility to manage their problems, reducing the
dosage of their medications and changing the times of tak-




n (%) n (%)
Depression 358 (89.50) 25 (6.25)
Anxiety 129 (32.25) 46 (11.50)
Stress 259 (64.75) 59 (14.75)
Group 1 (no/low symptoms) = normal +mild; group 2 (presence of symptoms) = moBy taking a lower dose of the medicine to minimize the
negative effects, a female participant said,
When the doctor told me he will not change my
medicine and I should still take the medicine like that, I
decided to divide the tablet into two and I only take half
of it. (R1: female).
Contrary to the information that diuretics were con-
venient when taken during the day, a patient thought it
better to do otherwise. According to her,
I take my medicine at night so I can go about my
day’s activities without having to urinate frequently.
(R2: female).
CAM use Complementary therapies were sometimes used
by participants to manage the negative effects of their con-
ventional medications:Moderate Severe Extremely severe
n (%) n (%) n (%)
12 (3.00) 4 (1.00) 1 (0.25)
140 (35.00) 44 (11.50) 41 (10.25)
52 (13.00) 26 (6.50) 4 (1.00)
derate + severe + extremely severe
Table 4 Logistic regression model for depression, anxiety and
stress symptoms in relation to the experience of side effects
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before taking my BP medication and I also use
dandelion and moringa for food to help solve the
problems with my medicine. (R1: female).
Additionally, alternative treatments were sought to
replace medications with unwanted effects. This view
was explicitly provided:
I use the natural way. I take fruits and feed myself on
fruits alone for say one week without taking my
medicine. When I do that I don’t feel anything bad
about the medication. So I believe that the natural
ways we were taught from the Bible saying we should
take fruits helps because when I try it, it works forTable 5 Frequency distribution for Morisky Medication Adherence Scal
Question
1. Do you sometimes forget to take your hypertension medications?
2. Over the past 2 weeks, were there any days when you did not take your hyp
3. Have you ever cut back or stopped taking your medication without telling yo
when you took it?
4. When you travel or leave home, do you sometimes forget to bring along you
5. Did you take your high blood pressure medicine yesterday?
6. When you feel like your blood pressure is under control, do you sometimes s
7. Do you ever feel hassled about sticking to your blood pressure treatment pla
8. How often do you have difficulty remembering to take all your medications?
○ Never/Rarely
○ Once in a while
○ Sometimes
○ Usually





Re-categorization of adherence level
Poor
High
Low and moderate adherence = poor adherenceme. I take banana, oranges, and pineapples in the
morning, maybe vegetables in the afternoon and fruits
in the evening. (R5: male).Intervention by doctors Some participants further indi-
cated the timely intervention by their doctors as serving
to deal with medication challenges. Patients usually had
the medications with the side effects changed by their
doctors. According to one participant:
I brought the medicine to the doctor at the next visit
and he changed it for me. (R3: female).
Similarly, a female participant admitted,
Formerly I was put on nifedipine and it came to a
time when I take it I feel severe headache so I
complained and the doctor changed it. (R10: female).
Likewise, another patient said,
I was given lisinopril and when I take it I cough a
lot so I told the doctor and he changed it for me.
(R13: female).e
Yes No
Freq. n (%) Freq. n (%)
282 (70.5) 118 (29.5)
ertension medicine? 328 (82.0) 72 (18.0)
ur doctor because you felt worse 341 (85.25) 59 (14.75)
r medications? 327 (81.75) 73 (18.25)
335 (83.75) 65 (16.25)
top taking your medicine? 340 (85.0) 60 (15)












Table 6 Logistic regression model for side effects and
non-adherence
Variable Odds ratio 95 % confidence
interval
p value
Moderate to high side effects
(ref: no/low side effects)
4.84 1.07–1.85 0.04
Demographic and clinical characteristics were controlled
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The majority (60 %) of hypertensive patients pointed out
that they experienced moderate to high side effects
which included difficulty sleeping, erectile dysfunction,
reduced sexual drive, constipation, chest pain, depressed
mood, headaches, cough, fatigue and dizziness. These
symptoms are consistent with what has been previously
reported and clearly outlined in medical literature [6]
and provide evidence that side effects play an important
role in the management of hypertension because of its
association with adherence to recommended remedies.
The present study observed that medication side ef-
fects potentially repressed adherence, and this role of
side effects as a major cause of non-adherence in both
new and old patients with hypertension is corrobo-
rated [8, 14–17].
In comparison with earlier investigations on medica-
tion side effects, the current study has also shown that
the roles of cognition, society, the media and the attitude
of clinicians were important in medication adherence
behaviour [18, 19]. First, remembering to take one’s
medication is a vital tool in aiding adherence to conven-
tional treatment [20]. Second, there is the heightened
need for clinicians to consider educating sexual partners
of male respondents who stop taking their medications
because they want to avoid the problem of erectile dys-
function. Similarly, experiences of medication side effects
had psychosocial underpinnings. For example, though the
feeling of erectile dysfunction is a biological issue, the
thought of becoming impotent has a strong psychological
impact on a man within the African cultural context [21].
Socially, the need to be able to satisfy sexual partners
would be an important issue of concern. This confirms
that social and behavioural issues are critical to clinical
care [22] and the need for emotional support to improve
adherence behaviour [23].
Media censoring can help to curb the influence of
superficial health information on the adherence behav-
iour of patients. Listening to information on medication
and their side effects led to non-adherence among some
participants. Yet the media could be probably explored
as a helpful tool to send important information highlighting
medication adherence [24].
The presence of common psychological problems such
as anxiety, depression and stress contributed to the extent
to which the participants experienced the side effects oftheir medications. Hypertensive patients experience intense
emotions which can increase their risk for the development
of mental health disorders particularly anxiety and depres-
sion, and these symptoms increase their susceptibility to
the negative effects of the medications [25].
To reduce the unpleasant nature of the side effects,
some participants were motivated to modify the dose or
the timing of medication intake, or have their regimen
amended by their clinicians. On the other hand, some
patients sought to use complementary and alternative
therapies. If, in contrast, the chemical composition of
the medications were perceived to be causing the ad-
verse effects, it could be argued that the use of CAM
was probably based on the perception that CAM rem-
edies are natural, less toxic and have relatively little or
no side effects [26].
This study acknowledges the limitation related to the
representativeness of the hypertensive patient samples
from the study sites which were both tertiary health
institutions. Although we collected data from the two
major institutions located in different regions of the
country, hypertensive patients are managed at other
levels of healthcare and information on such patients
were not obtained in the study.
Conclusions
Results from this study show that, in addition to a biomed-
ical approach, the experience of side effects has biological,
social and psychological interrelations. The result offer
more support for the need for a multi-disciplinary approach
to healthcare where all forms of expertise are incorporated
into health provision and patient care. Thus, addressing
this problem from a biopsychosocial perspective in any
intervention may improve adherence and invariably con-
trol blood pressure.
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